Magnetic resonance imaging in the evaluation of central nervous system manifestations in systemic lupus erythematosus
- PMID: 18084729
- DOI: 10.1007/s12016-007-8060-z
Magnetic resonance imaging in the evaluation of central nervous system manifestations in systemic lupus erythematosus
Abstract
Central nervous system (CNS) manifestations are often observed in systemic lupus erythematosus (SLE) patients during the course of their disease. The prevalence of CNS manifestations ranges between 17 and 75%, reflecting different methods of patient selection and assessment, varying levels of assessor expertise, and lack of a consensus for diagnosing active and chronic neuropsychiatric (NP) manifestations. Postulated pathogenic mechanisms of peripheral and CNS events include vasculopathy, autoantibody effects, and systemic inflammation. Diagnosis is often difficult because of the lack of standardized diagnostic techniques. Magnetic resonance imaging (MRI) is considered the gold standard for the evaluation of CNS manifestations in SLE patients in clinical practice. MRI findings are diverse, and atrophy and hyperintense white matter lesions often correlate poorly with clinical manifestations, occurring also in patients without marked CNS signs and symptoms. We will describe MRI findings in SLE patients and discuss the usefulness of different MRI techniques in evaluating acute and chronic CNS manifestations.
Similar articles
-
Distinct regional brain atrophy pattern in multiple sclerosis and neuropsychiatric systemic lupus erythematosus patients.Lupus. 2018 Sep;27(10):1624-1635. doi: 10.1177/0961203318781004. Epub 2018 Jun 27. Lupus. 2018. PMID: 29950159
-
Conventional brain magnetic resonance imaging in the longitudinal evaluation of newly diagnosed systemic lupus erythematosus patients: a retrospective analysis from a single-centre cohort.Lupus. 2020 Apr;29(5):499-504. doi: 10.1177/0961203320909955. Epub 2020 Mar 5. Lupus. 2020. PMID: 32138582
-
Neuropsychiatric systemic lupus erythematosus: magnetic resonance imaging findings and correlation with clinical and immunological features.Autoimmun Rev. 2013 Oct;12(12):1166-70. doi: 10.1016/j.autrev.2013.07.004. Epub 2013 Jul 11. Autoimmun Rev. 2013. PMID: 23851139
-
Magnetic resonance imaging in neuropsychiatric systemic lupus erythematosus: current state of the art and novel approaches.Lupus. 2017 Apr;26(5):517-521. doi: 10.1177/0961203317691373. Lupus. 2017. PMID: 28394232 Review.
-
Quantitative magnetic resonance imaging in neuropsychiatric systemic lupus erythematosus.Lupus. 2003;12(12):897-902. doi: 10.1191/0961203303lu499oa. Lupus. 2003. PMID: 14714908 Review.
Cited by
-
From Systemic Inflammation to Neuroinflammation: The Case of Neurolupus.Int J Mol Sci. 2018 Nov 13;19(11):3588. doi: 10.3390/ijms19113588. Int J Mol Sci. 2018. PMID: 30428632 Free PMC article. Review.
-
Diagnostic reliability of magnetic resonance imaging for central nervous system syndromes in systemic lupus erythematosus: a prospective cohort study.BMC Musculoskelet Disord. 2010 Jan 23;11:13. doi: 10.1186/1471-2474-11-13. BMC Musculoskelet Disord. 2010. PMID: 20096132 Free PMC article. Clinical Trial.
-
Diagnosis and management of neuropsychiatric SLE.Nat Rev Rheumatol. 2014 Jun;10(6):338-47. doi: 10.1038/nrrheum.2014.15. Epub 2014 Feb 11. Nat Rev Rheumatol. 2014. PMID: 24514913 Review.
-
Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers.Nat Rev Neurol. 2014 Oct;10(10):579-96. doi: 10.1038/nrneurol.2014.148. Epub 2014 Sep 9. Nat Rev Neurol. 2014. PMID: 25201240 Review.
-
Pattern of MRI brain in neuro-psychiatric SLE. Effect of anti-phospholipid antibodies: A study at a tertiary care teaching hospital.Pak J Med Sci. 2015 Sep-Oct;31(5):1182-7. doi: 10.12669/pjms.315.7975. Pak J Med Sci. 2015. PMID: 26649010 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous